Pixium Vision Logo

Pixium Vision

Develops bionic retinal implants to restore partial sight for macular degeneration patients.

ALPIX | PA

Overview

Corporate Details

ISIN(s):
FR0011950641 (+1 more)
LEI:
96950046OPLRLKKEOO08
Country:
France
Address:
74 RUE DU FBG ST ANTOINE, 75012 PARIS 12
Sector:
Manufacturing
Industry:
Manufacture of irradiation, electromedical and electrotherapeutic equipment

Description

Pixium Vision was a medical technology company that developed bionic vision systems to restore partial sight in patients with severe vision loss. Its flagship product is the PRIMA System, an innovative, wireless, photovoltaic sub-retinal implant. The system is designed for patients suffering from atrophic dry age-related macular degeneration (Dry-ARMD). It functions by converting light into electrical signals to stimulate retinal neurons, creating a form of artificial vision. The assets of Pixium Vision SA, including the PRIMA technology and its ongoing clinical trials, have been acquired by Science Corporation. La Science SAS is the current legal manufacturer and sponsor of the European clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-02-02 14:00
Legal Proceedings Report
Pixium Vision announces the rejection of the sale plan (plan de cession) by the…
English 156.7 KB
2024-02-02 14:00
Legal Proceedings Report
Pixium Vision annonce le rejet du plan de cession par le Tribunal et la convers…
French 165.4 KB
2024-01-17 17:00
Legal Proceedings Report
Postponement of the decision on the adoption of a sale plan (plan de cession) a…
English 157.2 KB
2024-01-17 17:00
Legal Proceedings Report
Report de la décision concernant l’arrêté d’un plan de cession et l’ouverture d…
French 165.3 KB
2024-01-17 07:00
Legal Proceedings Report
Report de la décision concernant l’arrêté d’un plan de cession et l’ouverture d…
French 164.0 KB
2024-01-17 07:00
Legal Proceedings Report
Postponement of the decision on the adoption of a sale plan (plan de cession) a…
English 156.4 KB
2023-12-18 19:00
Legal Proceedings Report
Decision concerning the adoption of a sale plan (plan de cession) and the openi…
English 157.8 KB
2023-12-18 19:00
Legal Proceedings Report
Décision concernant l’arrêté d’un plan de cession et l’ouverture d’une procédur…
French 166.4 KB
2023-12-04 07:00
Legal Proceedings Report
Audience d’examen de l’offre de reprise par le Tribunal de commerce prévue le 1…
French 167.1 KB
2023-12-04 07:00
Legal Proceedings Report
Commercial Court hearing to examine the takeover offer scheduled for December 1…
English 156.6 KB
2023-11-20 17:45
Legal Proceedings Report
Point sur la procédure de redressement judiciaire : dépôt d’une offre de repris…
French 165.4 KB
2023-11-20 17:45
Legal Proceedings Report
Update on the receivership proceedings: submission of a takeover offer to the c…
English 180.7 KB
2023-11-14 07:00
Legal Proceedings Report
Pixium Vision annonce les résultats de l'essai à 48 mois sur la DMLA atrophique…
French 284.3 KB
2023-11-14 07:00
Legal Proceedings Report
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD
English 263.7 KB
2023-11-13 20:00
Legal Proceedings Report
Pixium Vision annonce la conversion de sa procédure de sauvegarde en redresseme…
French 167.8 KB

Automate Your Workflow. Get a real-time feed of all Pixium Vision filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pixium Vision via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-01-10 N/A Other Sell 42,681 16,517.55 EUR
2024-01-09 N/A Other Sell 80,325 45,608.54 EUR
2024-01-08 N/A Other Sell 110,740 69,732.98 EUR
2023-12-04 N/A Other Sell 665 60.98 EUR

Peer Companies

Company Country Ticker View
Acarix Logo
AI-powered acoustic system for rapid, non-invasive rule-out of Coronary Artery Disease.
Sweden ACARIX
Develops a pain-free breath device to measure blood glucose for diabetes management.
Poland AME
Arcoma AB Logo
Develops and manufactures advanced digital X-ray and radiology solutions for global healthcare.
Sweden ARCOMA
ASTERASYS Co., Ltd. Logo
Develops HIFU and body analysis devices for the global aesthetic and healthcare market.
South Korea 450950
BIO PROTECH INC. Logo
Manufactures medical devices and consumables for surgery, cardiology, neurology & pain management.
South Korea 199290
Bistos Co., Ltd. Logo
Global maker of biosignal devices for patient monitoring, maternal-fetal, and neonatal care.
South Korea 419540
Develops software & hardware for precise surgical navigation and radiation therapy.
Germany N/A
Brainsway Ltd. Logo
Develops noninvasive Deep TMS therapy for depression, OCD, and smoking cessation.
Israel BWAY
AI-powered smart insoles providing gait analysis for neurological condition monitoring.
South Korea 352770
Chordate Medical Holding AB Logo
Develops drug-free neuromodulation tech for chronic migraine & rhinitis in the EU & Middle East.
Sweden CMH

Talk to a Data Expert

Have a question? We'll get back to you promptly.